Psagot Value Holdings Ltd. - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 35 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Psagot Value Holdings Ltd. ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q1 2019$240,000
+22.4%
55,2410.0%0.01%
+11.1%
Q4 2018$196,000
-7.1%
55,2410.0%0.01%0.0%
Q3 2018$211,000
-1.9%
55,2410.0%0.01%
-10.0%
Q2 2018$215,000
+74.8%
55,241
+41.2%
0.01%
+100.0%
Q1 2018$123,000
-19.6%
39,1150.0%0.01%
-28.6%
Q4 2017$153,000
-5.0%
39,1150.0%0.01%0.0%
Q3 2017$161,000
-0.6%
39,1150.0%0.01%0.0%
Q2 2017$162,000
-2.4%
39,1150.0%0.01%0.0%
Q1 2017$166,000
+66.0%
39,115
-0.2%
0.01%
+75.0%
Q4 2016$100,000
+6.4%
39,2030.0%0.00%0.0%
Q3 2016$94,000
+70.9%
39,203
+72.6%
0.00%
+100.0%
Q2 2016$55,000
-9.8%
22,7150.0%0.00%
-33.3%
Q1 2016$61,000
+96.8%
22,715
+112.0%
0.00%
+200.0%
Q4 2015$31,000
+24.0%
10,7150.0%0.00%0.0%
Q3 2015$25,000
-35.9%
10,7150.0%0.00%0.0%
Q2 2015$39,000
-18.8%
10,7150.0%0.00%
-50.0%
Q1 2015$48,00010,7150.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
Ikarian Capital, LLC 189,935$311,4940.08%
ABNER HERRMAN & BROCK LLC 280,000$4590.07%
Weaver Consulting Group 65,947$108,1530.06%
S.C. Financial Services, Inc. 25,372$41,6100.03%
JMAC ENTERPRISES LLC 40,430$66,3050.02%
Weaver Consulting Group 53,500$10,0470.01%
IFP Advisors, Inc 26,650$1390.00%
Bangor Savings Bank 4,000$70.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 3,000$4,9200.00%
BOOTHBAY FUND MANAGEMENT, LLC 19,098$31,3210.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders